Drugs for muscles and brains

Neurotune AG
Wagistrasse 27a
8952
Schlieren-Zürich
8952 Schlieren-Zürich
Auf Karte anzeigen
044 200 21 95
044 200 20 10
toe@neurotune.com
www.neurotune.com
Firmenbeschrieb
Neurotune, based in Schlieren (Zurich), Switzerland, was incorporated in January 2005 as a spin-off from Prionics AG. Neurotune develops small-molecular drugs to treat disorders of the human peripheral and central nervous system, as well as drugs to treat age-related muscle atrophy – Sarcopenia. The enormous economic potential of novel drugs for the treatment of central nervous system disorders lays ground for a successful development of the company. The scope of activities at Neurotune is drug development from preclinical R&D up to clinical Phase II out-licensing at the stage of clinical Phase II in-licensing of drug candidates Our core competences lie in biochemistry, neurological disorders of the central and peripheral nervous system medicinal chemistry on small molecular drugsGründungsjahr
2005
Rechtsform
Aktiengesellschaft (AG)
Anzahl Mitarbeiter
20
Eintrag erstellt: 05.10.2006, Letzte Änderung: 05.10.2006
